Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
AI Finding Twice as Many Cyber Flaws in 2026 as It Did in 2025 
Company at Center of Cyclospora Outbreak Complained to White House, Source Says 
Lemonade Posts $43M Loss for Q2 as it Continues to Grow Customer Base 
Record-Low Danube Water Levels Leave Boats Beached, Reveal Decades-Old Shipwrecks 
